10-02-14
Member news
UPM Raflatac at Pharmapack 2014:
Leading pharmaceutical labelling solutions backed by global resources and local support
UPM Raflatac is exhibiting at Pharmapack 2014 in Paris, France, on 12-13 February. A team of pharmaceutical labelling experts will be present to discuss products fulfilling a wide variety of needs in pharmaceutical and healthcare labelling.
One of UPM Raflatac’s key innovations featuring at Pharmapack is the migration-safe RP 31 Purus adhesive. RP 31 Purus has been specially developed for labelling liquid-filled containers made from non-glass materials such as LDPE. This high-performance adhesive meets and exceeds all requirements in medical, pharmaceutical and healthcare applications where the risk of migration must be minimized. It is also a safe choice for labelling on small diameters.
RP 31 Purus complies with the demands of the Code of Federal Regulations, Food and Drugs Administration (FDA), 21 CFR Ch. I (April 1, 2011 edition) 175.105, and meets European Food contact regulations based on Food Framework Regulation 1935/2004. RP 31 Purus is also covered by a global change management processes which includes a minimum 12 months’ notice to qualify new materials, a last-call option to allow bulk purchasing before production discontinuation, and a minimum of 36 months’ rolling availability.
Visitors to Pharmapack are invited to find out more about UPM Raflatac’s pharmaceutical product range – dedicated paper and film label faces, and adhesives with properties such as high cohesion for small-diameter labelling, luminescence for missing label detection, and resistance to sterilization. Options for integrated security and anti-counterfeiting features are available to protect patient and consumer safety, traceability and brand equity. All UPM Raflatac products are backed by one-to-one customer service on the local level and the technical and R&D resources of a global leader in self-adhesive labelling.
UPM Raflatac is exhibiting at Pharmapack 2014 in Paris, France, on 12-13 February. A team of pharmaceutical labelling experts will be present to discuss products fulfilling a wide variety of needs in pharmaceutical and healthcare labelling.
One of UPM Raflatac’s key innovations featuring at Pharmapack is the migration-safe RP 31 Purus adhesive. RP 31 Purus has been specially developed for labelling liquid-filled containers made from non-glass materials such as LDPE. This high-performance adhesive meets and exceeds all requirements in medical, pharmaceutical and healthcare applications where the risk of migration must be minimized. It is also a safe choice for labelling on small diameters.
RP 31 Purus complies with the demands of the Code of Federal Regulations, Food and Drugs Administration (FDA), 21 CFR Ch. I (April 1, 2011 edition) 175.105, and meets European Food contact regulations based on Food Framework Regulation 1935/2004. RP 31 Purus is also covered by a global change management processes which includes a minimum 12 months’ notice to qualify new materials, a last-call option to allow bulk purchasing before production discontinuation, and a minimum of 36 months’ rolling availability.
Visitors to Pharmapack are invited to find out more about UPM Raflatac’s pharmaceutical product range – dedicated paper and film label faces, and adhesives with properties such as high cohesion for small-diameter labelling, luminescence for missing label detection, and resistance to sterilization. Options for integrated security and anti-counterfeiting features are available to protect patient and consumer safety, traceability and brand equity. All UPM Raflatac products are backed by one-to-one customer service on the local level and the technical and R&D resources of a global leader in self-adhesive labelling.